
GC75511
HSP90-IN-22
Also known as N-[2-(4-ethylpiperazin-1-yl)-4-methylquinolin-6-yl]-3,4-dimethoxybenzamide
HSP90-IN-22 (Compound 35) is an Hsp90 inhibitor with antiproliferative properties on cells with IC50 values of 3·65 μM for MCF7 breast cancer cells and 2·71 μM for SKBr3 breast cancer cells, respectively
ChemicalCAS442898-75-1MW434.53FormulaC25H30N4O3
- CAS number
- 442898-75-1
- Molecular weight
- 434.53
- Formula
- C25H30N4O3
- Solubility
- DMSO: 100 mg/mL (230·13 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- YGHVMEYBSUHIGF-UHFFFAOYSA-N
- Catalogue number
- GC75511
- Brand
- GLPBIO
Computed properties PubChem CID 9550693 · XLogP 4 · TPSA 66.9 Ų · H-bond donors 1
- XLogP
- 4
- TPSA
- 66.9 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 32
SMILES CCN1CCN(CC1)C2=NC3=C(C=C(C=C3)NC(=O)C4=CC(=C(C=C4)OC)OC)C(=C2)C
Computed descriptors from PubChem (CID 9550693), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il